Treat IDH2 mutated acute myeloid leukemia with Idhifa 50mg Tablet

It is a prescription-based anticancer medicine Idhifa 50mg Tablet for relapsed or refractory AML with IDH2 mutation. It works by targeting and inhibiting the mutant IDH2 enzyme, helping to reduce cancer cell growth and support better treatment outcomes. For more information visit Globans Pharma official website.
https://www.globanspharma.com/products/idhifa-50mg-tablet